Location History:
- Faches-Tumesnil, FR (2009)
- Faches-Thunesnil, FR (2011)
- Faches-Thumesnil, FR (2005 - 2023)
Company Filing History:
Years Active: 2005-2025
Title: **The Innovations of Francis Goudaliez: A Leader in Platelet Lysate Sterilization**
Introduction
Francis Goudaliez, based in Faches-Thumesnil, France, is an accomplished inventor with a noteworthy portfolio of 18 patents. His groundbreaking work focuses primarily on the field of biomedical innovations, specifically in the sterilization of platelet lysates which are critical in therapeutic applications.
Latest Patents
Among his significant contributions, Goudaliez's latest patents include a method for sterilizing a platelet lysate in the liquid state. This method involves utilizing endogenous growth factors such as TGF-beta 1, EGF, PDGF-AB, IGF-1, VEGF, and bFGF. The innovative process begins by freezing the liquid platelet lysate to create a frozen product, which is then irradiated with ionizing radiation. This carefully calibrated irradiation preserves at least 80% of the concentration of one or more of the crucial growth factors, enhancing the efficacy and safety of the platelet lysate in medical applications.
Career Highlights
Throughout his career, Francis Goudaliez has made substantial impacts in the biomedical space, particularly concerning the development of methodologies that improve the handling and application of platelet lysates. His inventions have not only advanced medical treatment options but have contributed to the overall understanding of growth factor dynamics in therapeutic environments.
Collaborations
Goudaliez has worked with esteemed companies such as Macopharma and Maco Pharma S.A., where his expertise has been integral in driving innovative solutions in medical technology. In addition, he has collaborated with notable colleagues, including Thierry Verpoort and Maurice Behague, contributing to a robust exchange of ideas and advancements in their field.
Conclusion
Francis Goudaliez stands out as a significant figure in the realm of biomedicine, particularly in the innovation of platelet lysate treatments. His 18 patents underscore his commitment to advancing medical technologies that prioritize safety and efficacy, paving the way for more effective therapeutic solutions in the healthcare industry.